CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions		Dec. 31, 2022	Dec. 31, 2021
ASSETS:
Cash and due from banks		$ 1,489	$ 1,155
Interest-bearing cash and due from banks		9,058	8,003
Interest-bearing deposits in banks		303	316
Debt securities available for sale, at fair value (including $— and $640 pledged to creditors, respectively)	[1]	24,007	26,067
Debt securities held to maturity (fair value of $— and $2,289, respectively, and including $— and $77 pledged to creditors, respectively)	[1]	9,834	2,242
Loans held for sale, at fair value		774	2,733
Other loans held for sale		208	735
Loans and leases		156,662	128,163
Less: Allowance for loan and lease losses		(1,983)	(1,758)
Net loans and leases		154,679	126,405
Derivative assets		842	1,216
Premises and equipment, net		844	768
Bank-owned life insurance		3,236	2,843
Goodwill		8,173	7,116
Other intangible assets	[2]	197	64
Other assets		13,089	8,746
TOTAL ASSETS		226,733	188,409
Deposits:
Noninterest-bearing		49,283	49,443
Interest-bearing		131,441	104,918
Total deposits		180,724	154,361
Short-term borrowed funds		3	74
Derivative liabilities		1,909	197
Long-term borrowed funds		15,887	6,932
Other liabilities		4,520	3,425
TOTAL LIABILITIES		203,043	164,989
Commitments and Contingencies (refer to Note 19)
Preferred Stock:
$25.00 par value,100,000,000 shares authorized; 2,050,000 shares issued and outstanding at December 31, 2022 and 2021		2,014	2,014
Common stock:
$0.01 par value, 1,000,000,000 shares authorized; 645,220,018 shares issued and 492,282,158 shares outstanding at December 31, 2022 and 571,259,135 shares issued and 422,137,197 shares outstanding at December 31, 2021		6	6
Additional paid-in capital		22,142	19,005
Retained earnings		9,159	7,978
Treasury stock, at cost, 152,937,860 and 149,121,938 shares at December 31, 2022 and 2021, respectively		(5,071)	(4,918)
Accumulated other comprehensive income (loss)		(4,560)	(665)
TOTAL STOCKHOLDERS’ EQUITY		23,690	23,420
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY		$ 226,733	$ 188,409

[1] Includes only collateral pledged by the Company where counterparties have the right to sell or pledge the collateral.

[2] Excludes MSRs, which are reported in Other assets.